The global endoluminal suturing devices market size reached US$ 64.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 128.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.40% during 2023-2028. The increasing emphasis on cost-effectiveness and efficiency in healthcare systems, the availability of robust clinical evidence demonstrating efficacy and positive outcomes, and the rising prevalence of chronic diseases among the masses are some of the major factors propelling the market.
|Market Size in 2022
||US$ 64.2 Million
|Market Forecast in 2028
||US$ 128.7 Million
|Market Growth Rate (2023-2028)
Endoluminal suturing devices are innovative medical tools used in minimally invasive procedures to suture or stitch tissues within the body. They are specifically designed for use in endoluminal or intraluminal applications, meaning they are used inside the body's hollow organs or vessels, such as the gastrointestinal tract or blood vessels. Endoluminal suturing devices provide surgeons the ability to execute suturing procedures without the need for open surgery, minimizing patient stress, postoperative problems, and recovery time. Additionally, they consist of a flexible shaft with a suturing mechanism attached at the tip, which enables precise needle placement and controlled suturing. Some endoluminal suturing devices incorporate robotic or computer-assisted technology to enhance surgical precision and accuracy.
The growing emphasis on cost-effectiveness and efficiency in healthcare systems majorly drives the global market. These devices enable healthcare providers to optimize resources, minimize costs associated with prolonged hospital stays, and improve overall healthcare efficiency. Additionally, the escalating demand for endoluminal suturing devices as healthcare organizations strive to streamline their operations and maximize resource utilization is significantly supporting the market. In addition, the availability of robust clinical evidence demonstrating the efficacy and positive outcomes associated with endoluminal suturing devices plays a crucial role in impelling market growth. Clinical studies, research publications, and real-world data showcasing the benefits and success rates of these devices contribute to their wider acceptance and adoption in clinical practice. Some of the other factors driving the market include improvements in the healthcare infrastructure and extensive research and development activities.
Endoluminal Suturing Devices Market Trends/Drivers:
Growing Preference for Minimally Invasive Procedures
One significant market driver for endoluminal suturing devices is the increasing preference for minimally invasive procedures among both patients and healthcare providers. Minimally invasive surgeries offer numerous advantages over traditional open surgeries, including reduced pain, shorter hospital stays, quicker recovery times, and minimal scarring. Endoluminal suturing devices play a vital role in enabling these procedures by allowing surgeons to suture tissues internally without the need for large incisions. Moreover, the demand for minimally invasive procedures is driven by technological advancements that have improved the capabilities of endoluminal suturing devices. These devices offer enhanced maneuverability, better visualization, and improved suturing techniques, making them highly valuable tools for surgeons in various medical specialties.
Rising Prevalence of Chronic Diseases
The rising prevalence of chronic diseases, such as obesity, cardiovascular disorders, and gastrointestinal conditions, is another significant market driver for endoluminal suturing devices. These devices are frequently used in the treatment of such diseases, as they offer a minimally invasive approach to surgical interventions. For instance, in the field of bariatric surgery, endoluminal suturing devices enable the performance of procedures, such as gastric sleeve or gastric bypass, which help patients achieve weight loss and manage obesity-related comorbidities. Also, as the global burden of chronic diseases continues to escalate, the demand for endoluminal suturing devices is growing. With the ability to address conditions in a minimally invasive manner, these devices offer patients the benefits of reduced surgical risks, faster recovery, and improved quality of life.
Advancements in Endoluminal Suturing Technologies
Advancements in endoluminal suturing technologies serve as a key market driver for these devices. Ongoing research and development efforts are focused on enhancing the precision, functionality, and ease of use of these devices, thereby driving their adoption in the medical community. For instance, the incorporation of robotic-assisted technology into endoluminal suturing devices has led to more precise and accurate suturing procedures. Robotic systems provide enhanced dexterity and stability, enabling surgeons to perform intricate suturing tasks with greater ease. Furthermore, the integration of imaging technologies, such as fluoroscopy or endoscopy, offers real-time visualization during suturing procedures, improving procedural outcomes, which is creating a positive market outlook.
Endoluminal Suturing Devices Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global endoluminal suturing devices report, along with forecasts at the global, regional and country levels for 2023-2028. Our report has categorized the market based on application and end use.
Breakup by Application:
- Bariatric Surgery
- Gastrointestinal Surgery
- Gastroesophageal Surgery
Gastrointestinal surgery dominates the market
The report has provided a detailed breakup and analysis of the endoluminal suturing devices market based on the application. This includes bariatric surgery, gastrointestinal surgery, gastroesophageal surgery, and others. According to the report, gastrointestinal surgery represented the largest segment.
The growing prevalence of gastrointestinal disorders and diseases, such as gastroesophageal reflux disease (GERD), gastric ulcers, and colorectal cancer, which require surgical interventions is significantly supporting the market. Endoluminal suturing devices offer a minimally invasive approach for gastrointestinal surgeries, reducing patient trauma, postoperative complications, and recovery time. Moreover, the development of specialized suturing mechanisms, such as flexible robotic systems and advanced suturing techniques, allows surgeons to perform complex suturing tasks within the gastrointestinal tract with enhanced precision and control.
On the contrary, the escalating demand for minimally invasive procedures among the masses is one of the significant drivers for gastroesophageal surgery applications in the endoluminal suturing devices industry. Endoluminal suturing devices enable surgeons to perform these procedures with minimal trauma and scarring, contributing to better patient experiences. Additionally, the availability of clinical evidence and regulatory approvals supporting the use of endoluminal suturing devices in gastroesophageal surgeries drives the market. Clinical studies and research publications highlight the safety, efficacy, and positive outcomes associated with these devices in gastroesophageal surgery.
Breakup by End Use:
- Ambulatory Surgical Centers
Hospitals hold the largest share in the market
A detailed breakup and analysis of the endoluminal suturing devices market based on the end use has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.
Several factors are driving the growth of endoluminal suturing devices in the hospital end-use sector, including the rising prevalence of gastrointestinal diseases and obesity is one of the primary drivers. The increase in minimally invasive surgeries and the need for more efficient, safer surgical procedures are also catalyzing the demand. Additionally, advancements in technology are improving the effectiveness of endoluminal suturing devices, making them an attractive option for healthcare providers. In addition, the growing adoption of bariatric procedures and endoscopic surgeries in hospitals due to the high success rate and lesser recovery time further escalates the demand.
On the other hand, the rise in outpatient surgeries attributable to lower costs and shorter hospital stays is encouraging the use of these devices in ambulatory surgical centers. Technological advancements have also made these procedures safer and more efficient, increasing their popularity in these settings. In confluence with this, these centers are becoming more equipped to handle complex procedures, such as endoluminal suturing due to the continual training of medical professionals and the acquisition of sophisticated medical devices.
Breakup by Region:
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest the endoluminal suturing devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
The endoluminal suturing devices industry in North America is being driven by the growing prevalence of chronic diseases such as obesity and gastrointestinal disorders, which require minimally invasive surgical procedures. Endoluminal suturing devices offer a less invasive alternative to traditional open surgeries, resulting in reduced hospital stays, faster recovery, and lower healthcare costs.
Additionally, technological advancements in endoluminal suturing devices have improved their efficacy and ease of use, attracting both healthcare professionals and patients. These devices now offer enhanced precision, real-time imaging, and better suturing techniques, making them more appealing for surgeons. Moreover, the increasing geriatric population in North America, coupled with the rising demand for bariatric and gastrointestinal surgeries, is also contributing to the market.
On the contrary, Asia Pacific is estimated to expand further in this domain due to the rising lifestyle disorders, such as obesity and diabetes in countries, including China and India, leading to an increased demand for minimally invasive surgical procedures. In addition, the growing awareness among healthcare professionals about the benefits of endoluminal suturing techniques is further fuelling the demand for these devices. Furthermore, advancements in technology and product innovation are enhancing the performance and usability of endoluminal suturing devices, making them more appealing to physicians in the Asia Pacific region.
The global endoluminal suturing devices market is experiencing significant growth due to the improvements in suturing techniques, the development of new features such as real-time imaging and robotic assistance and optimizing the usability and safety of their devices. Therefore, companies are introducing new endoluminal suturing devices to the market, incorporating the latest advancements in technology. These product launches aim to meet the evolving needs of healthcare professionals, offering improved efficiency, precision, and patient outcomes. In addition, numerous companies form partnerships and collaborations with hospitals, research institutions, and other industry players. These collaborations facilitate knowledge sharing, joint research projects, and product development initiatives, enabling companies to leverage collective expertise and resources. Moreover, endoluminal suturing device manufacturers adhere to stringent regulatory standards to ensure the safety and efficacy of their products. They work closely with regulatory bodies to obtain necessary approvals and certifications for their devices, ensuring compliance with regional and international regulations.
The report has provided a comprehensive analysis of the competitive landscape in the global endoluminal suturing devices market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Apollo Endosurgery Inc.
- Ovesco Endoscopy AG
- Usgi Medical Inc.
Endoluminal Suturing Devices Market Report Scope:
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- End Use
||Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Surgery, Others
|End Uses Covered
||Hospitals, Ambulatory Surgical Centers, Others
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Apollo Endosurgery Inc., ErgoSuture, Ovesco Endoscopy AG, Usgi Medical Inc., etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global endoluminal suturing devices market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global endoluminal suturing devices market?
- What is the impact of each driver, restraint, and opportunity on the global endoluminal suturing devices market?
- What are the key regional markets?
- Which countries represent the most attractive endoluminal suturing devices market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the endoluminal suturing devices market?
- What is the breakup of the market based on the end use?
- Which is the most attractive end use in the endoluminal suturing devices market?
- What is the competitive structure of the global endoluminal suturing devices market?
- Who are the key players/companies in the global endoluminal suturing devices market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the endoluminal suturing devices market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global endoluminal suturing devices market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the endoluminal suturing devices industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.